Walleye Trading LLC Bio N Tech Se Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$78.36 - $124.66 $1.68 Million - $2.67 Million	21,400 Added 72.05%	51,100 $6.07 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $1.47 Million - $1.88 Million	-18,300 Reduced 38.13%	29,700 $2.39 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $2.01 Million - $2.54 Million	-22,600 Reduced 32.01%	48,000 $4.43 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $172,729 - $214,225	1,900 Added 2.77%	70,600 $7.45 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $1.46 Million - $1.85 Million	14,800 Added 27.46%	68,700 $7.46 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $1.28 Million - $1.62 Million	12,500 Added 30.19%	53,900 $5.82 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $1.18 Million - $1.48 Million	-9,600 Reduced 18.82%	41,400 $5.16 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $734,266 - $1.15 Million	6,200 Added 13.84%	51,000 $7.66 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $1.12 Million - $1.61 Million	-8,800 Reduced 16.42%	44,800 $6.04 Million
Q2 2022 Aug 08, 2022	BUY	$123.25 - $186.24 $308,125 - $465,600	2,500 Added 4.89%	53,600 $7.99 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $2.23 Million - $4.1 Million	17,700 Added 52.99%	51,100 $8.72 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $368,288 - $616,284	1,700 Added 5.36%	33,400 $8.61 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $638,383 - $1.39 Million	3,100 Added 10.84%	31,700 $8.65 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $2.29 Million - $4.88 Million	20,200 Added 240.48%	28,600 $6.4 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $720,132 - $1 Million	8,400 New	8,400 $917,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account